3-n-methylspiperone has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anders, P; Brandt, J; Dannals, RF; Folstein, SE; Links, J; McDonnell-Sill, A; Starkstein, S; Strauss, ME; Tune, LE; Wong, DF | 1 |
| Aquilonius, SM; Bergström, K; Eckernäs, SA; Hägglund, J; Hartvig, P; Långström, B; Lundqvist, H; Malmborg, P; Någren, K | 1 |
| Aquilonius, SM; Eckernäs, SA; Gullberg, P; Hägglund, J; Hartvig, P; Långström, B; Lundquist, H | 1 |
3 other study(ies) available for 3-n-methylspiperone and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
Topics: Adult; Brain; Brain Mapping; Caudate Nucleus; Cerebellum; Dopamine Agents; Female; Humans; Huntington Disease; Male; Neuropsychological Tests; Putamen; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Risk Factors; Spiperone; Tomography, Emission-Computed | 1990 |
Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease.
Topics: Brain; Cerebellum; Cerebral Cortex; Corpus Striatum; Humans; Huntington Disease; Kinetics; Parkinson Disease; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1987 |
Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
Topics: Aged; Caudate Nucleus; Corpus Striatum; Female; Frontal Lobe; Humans; Huntington Disease; Kinetics; Male; Parkinson Disease; Putamen; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1987 |